SHELTON CAPITAL MANAGEMENT

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1002784 Denver, CO

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$363,534

+$83,892 QoQ

Shares Held

4,460

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#328

of 497 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SHELTON CAPITAL MANAGEMENT holds $30,019,192 across 14 Biotechnology names. ARWR ranks #8 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	29,423	$14,615,286
2	REGN	Regeneron Pharmaceuticals, Inc.	11,459	$7,145,144
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,556	$4,381,792
4	ROIV	Roivant Sciences Ltd.	14,598	$516,623
5	JAZZ	Jazz Pharmaceuticals plc	1,967	$473,987
6	EXEL	Exelixis, Inc.	8,157	$443,822
7	PRTA	Prothena Corp Public Ltd Co	39,472	$386,430
8	ARWR	Arrowhead Pharmaceuticals, Inc. This page	4,460	$363,534

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$363,534	4,460	0.0%	Shares	Sole	2026-08-14
2026-03-31	$279,642	4,460	-6.4%	Shares	Sole	2026-05-15
2025-12-31	$316,348	4,765	-13.8%	Shares	Sole	2026-02-17
2022-12-31	$224,094	5,525	0.0%	Shares	Sole	2023-02-13
2022-03-31	$254,094	5,525	0.0%	Shares	Sole	2022-05-12
2021-12-31	$366,307	5,525	-4.4%	Shares	Sole	2022-02-11
2021-09-30	$360,658	5,777	0.0%	Shares	Sole	2021-11-15
2021-06-30	$478,451	5,777	0.0%	Shares	Sole	2021-08-12
2021-03-31	$383,072	5,777	0.0%	Shares	Sole	2021-05-14
2020-12-31	$443,269	5,777	-4.2%	Shares	Sole	2021-02-16
2020-09-30	$259,694	6,031	0.0%	Shares	Sole	2020-11-09
2020-06-30	$260,478	6,031	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.